JEREMIAH MORENO: Open Payments
NPI 1457957953 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 34 payments from 9 companies in 2025. Trend: 2023 $568 · 2024 $534 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $245 |
| Merck Sharp & Dohme LLC | 7 | $146 |
| Actelion Pharmaceuticals US, Inc. | 4 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $104 |
| ABIOMED | 1 | $100 |
| SCPHARMACEUTICALS INC. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| United Therapeutics Corporation | 2 | $45 |
| PFIZER INC. | 1 | $18 |
Products named: FARXIGA, JARDIANCE, OPSUMIT, FUROSCIX, WINREVAIR, VERQUVO, Adempas, OPSYNVI.
Industry payments across NM — which companies pay providers there.
